Jinghao Medical 锦好医疗
17 significant filings since 31 May 2026: 8 on buyback, 5 on equity incentive and 2 on change of interest, and 2 other kinds. The latest, on 17 Sep 2026: 限制性股票激励计划限制性股票解除限售公告. On 25 Aug 2026 the company said it expects net profit for the period ending 30 Sep 2026 to change by an amount it did not state from the same period a year earlier.
自 31 May 2026 起有 17 份重大公告：buyback 8 份、equity incentive 5 份、change of interest 2 份，另有 2 类。最新一份（17 Sep 2026）：限制性股票激励计划限制性股票解除限售公告。25 Aug 2026 公司预告截至 30 Sep 2026 的净利润较上年同期变动幅度未披露。
No broker reports from the last twelve months are held for this company. Brokers covered 208 of the 347 BSE listings (60%) over the same period. 近十二个月无本公司研报；同期券商覆盖了 347 只 BSE 证券中的 208 只（60%）。
No broker has changed its rating on this company in the reports held.
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。